Kalos, Michael
Next Pillar Consulting,
United States
2024 Rank: 76392
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1538 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 76392 | 83994 |
| Total Cites | 1422 | 1475 |
| H-index | 19 | 20 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 132 | 134 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 253 | 259 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1074 | 1105 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.33 |
| Self-Citation Percentage |
3.59%
|
|
Kalos, Michael
Eli Lilly and Company,
United States
2023 Rank: 56369
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1239 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 56369 | 64305 |
| Total Cites | 1717 | 1777 |
| H-index | 22 | 22 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 165 | 171 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 281 | 293 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1259 | 1294 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.37 |
| Self-Citation Percentage |
3.38%
|
|
Kalos, Michael
Eli Lilly and Company,
United States
2022 Rank: 43567
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1108 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 43567 | 49670 |
| Total Cites | 1876 | 1951 |
| H-index | 23 | 23 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 179 | 184 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 317 | 328 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1379 | 1423 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.37 |
| Self-Citation Percentage |
3.84%
|
|
Kalos, Michael
Eli Lilly and Company,
United States
2021 Rank: 46344
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1079 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46344 | 51264 |
| Total Cites | 2881 | 3043 |
| H-index | 26 | 26 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 279 | 287 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 470 | 492 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2047 | 2127 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.43 |
| Self-Citation Percentage |
5.32%
|
|
Kalos, Michael
Arsenal Biosciences,
United States
2020 Rank: 50722
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1097 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 50722 | 51664 |
| Total Cites | 2207 | 2369 |
| H-index | 21 | 23 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 227 | 240 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 355 | 383 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1421 | 1497 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.58 |
| Self-Citation Percentage |
6.84%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.